It has been reported that Sjp40 was therapeutically effective in the hepatic fibrosis model by preventing the activation of HSCsin vitro and suppressing the TGF-β and extracellular signal-regulated kinase signaling pathways[44]. Here, TGFB1 is linked to Hepatic fibrosis.